3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is increasingly attracting clinical scrutiny due to initial data suggesting different pharmacological characteristics. Preliminary studies https://www.pinterest.com/pin/1140888518124046392/